Depo Provera Meningioma in New Jersey

Residents of New Jersey: New Research Links Depo Provera to Meningioma

Injectable birth control, known by its brand name Depo Provera, along with two other similar drugs, medrogestone and promegestone, have been found to significantly increase New Jersey women's risk for meningioma brain tumors. A large study out of France confirms what has long been a suspected link between Depo Provera and meningioma, showing the world that this popular method of birth control carries with it life-threatening risks.

Though the exact reason for the link will require additional research to confirm, current research suggests that high doses of progestin, a synthetic version of the human hormone progesterone, galvanize the growth of meningioma cells. Attorneys handling Depo Provera meningioma lawsuits for New Jersey residents believe persons and the family members of persons who have been diagnosed with meningioma after using Depo Provera for at least a year in New Jersey may be eligible for significant compensation. This page provides a comprehensive look overview of the Depo Provera meningioma link for New Jersey residents.

New Jersey Residents: Depo Provera Birth Control Injection Information

Depo Provera, which is the same as the generic medroxyprogesterone acetate, is a form of birth control that is used by women in New Jersey, given every three months as an injection. Designed to prevent pregnancy through stopping the monthly release of eggs, thickening cervical mucus to prevent sperm from reaching the egg, and thinning the uterine lining to prevent implantation, Depo Provera works by delivering a high dose of progestin. Progestin is a synthetic version of a natural hormone, progesterone.

First discovered by Upjohn Co. in 1959, Depo Provera is now available in New Jersey by brand-name from Pfizer and as a generic from several other pharmaceutical companies. Depo Provera was approved as a safe and reliable contraceptive by the FDA in 1992. More than one in five women have used Depo Provera or a generic in the United States, and the birth control injection is used by 74 million worldwide.

Two other drugs, medrogestone and promegestone, utilize a substantial dose of the synthetic hormone progestin. These drugs are prescribed to New Jersey women to manage a range of conditions including endometriosis, polycystic ovary syndrome, and in hormone replacement therapy during menopause.

Depo Provera and Meningiomas in New Jersey

Generally deemed safe and effective for most women in New Jersey, researchers are learning that Depo Provera may come with unexpected and severe risks. Specifically, concerns have arisen regarding a possible link between repeated Depo Provera injections and an increased risk of meningiomas, a type of brain tumor which is most often not cancerous but still poses serious health risks to New Jersey women.

Along with Depo Provera, two other medications containing high progestin doses have also been found to elevate the risk of brain tumors. Research indicates medrogestone and promegestone can heighten the risk of meningioma brain tumor for New Jersey women by 4.1 times and 2.7 times, respectively.

Meningiomas are typically non-malignant or non-cancerous. That said, New Jersey meningioma brain tumors are still associated with significant dangers and risks. Located in the lining of the brain and spinal cord, meningiomas necessitate brain surgery and sometimes radiation. Neurosurgery carries inherent risks such as seizures, brain damage, and other potential harms. Even if initial treatment is successful, Depo Provera-related brain tumors in New Jersey can recur at a later time.

Recent research links the use of Depo Provera, medrogestone, and promegestone for at least one year to an elevated risk of meningioma for women in New Jersey. Meningiomas are the most frequent type of primary brain tumor, constituting about one-third of all such tumors. A higher prevalence in women than men has prompted researchers to investigate potential hormonal influences on their development. Moreover, researchers note that progesterone hormone receptors are present in over 60% of meningiomas, suggesting a plausible connection between the hormone and the growth of these brain tumors. Used by women in New Jersey, each of these drugs delivers a high dosage of a synthetic version of progesterone known as progestin.

Women in New Jersey have had no warning of this danger becase the drug inserts for Depo Provera, promegestone, and medrogestone do not contain meningioma warnings. Symptoms of meningioma brain tumors include hearing loss / ringing in the ears, loss of smell, change in vision, memory loss, seizures, headaches, and weakened arms or legs.

Residents of New Jersey: Depo Provera Meningioma Research

Research on the Depo Provera meningioma link has just emerged in the last two years, and women in New Jersey are just beginning to learn of the danger. In 2023, a study that included a small number of women was published in the Journal of Neurological Surgery. Researchers from the University of Pittsburgh determined that, "There appears to be a clear progestin meningioma syndrome associated with chronic DMPA (Depo Provera) use."

Though the link between Depo Provera and meningioma has been suspected in the past, the study published by French researchers in the British Medical Journal in early 2024 provides clear evidence behind this connection. Over 100,000 women were included in this Depo Provera meningioma study over a 10 year span. Of those, more than 18,000 were confirmed to have developed a meningioma brain tumor. Based on whether the women had received birth control injections in the year prior to their diagnosis, New Jersey women have been alarmed to learn that researchers found that Depo Provera increases the risk of meningioma by 5.6 times.

Let Our Depo Provera Meningioma Lawyers Serving New Jersey Help You

Our attorneys specialize in holding large corporations accountable when they've placed profits ahead of safety. Through settlements and winning verdicts, our attorneys have obtained millions for our clients. Let us help you today.

Depo Provera Meningioma Lawsuits for New Jersey Residents

Filing a lawsuit will allow you to hold the pharmaceutical company accountable for damage it has caused you or a loved one, while also providing real compensation for your medical expenses, suffering and loss. Contact us today for a free consultation.